nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antimalarials as a risk factor for elevated muscle enzymes in systemic lupus erythematosus
|
Tselios, K |
|
2016 |
25 |
5 |
p. 532-535 |
artikel |
2 |
Anti-Ro/SSA autoantibody-positive women’s experience of information given on the risk of congenital heart block
|
Tingström, J |
|
2016 |
25 |
5 |
p. 536-542 |
artikel |
3 |
Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis
|
Sharma, S K |
|
2016 |
25 |
5 |
p. 525-531 |
artikel |
4 |
Evaluation of left atrial function by speckle tracking echocardiography in patients with systemic lupus erythematosus
|
Dai, M |
|
2016 |
25 |
5 |
p. 496-504 |
artikel |
5 |
Iloprost treatment in pediatric patients with complicated Raynaud's phenomenon
|
Cekic, S |
|
2016 |
25 |
5 |
p. 558-560 |
artikel |
6 |
Increased serum level of prolactin is related to autoantibody production in systemic lupus erythematosus
|
Yang, J |
|
2016 |
25 |
5 |
p. 513-519 |
artikel |
7 |
Musculoskeletal manifestations of the antiphospholipid syndrome
|
Noureldine, M H A |
|
2016 |
25 |
5 |
p. 451-462 |
artikel |
8 |
Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years
|
Srivastava, P |
|
2016 |
25 |
5 |
p. 547-557 |
artikel |
9 |
Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study)
|
Bazzan, M |
|
2016 |
25 |
5 |
p. 479-485 |
artikel |
10 |
Primary antiphospholipid syndrome: absence of premature atherosclerosis in patients without traditional coronary artery disease risk factors
|
Andrade, D |
|
2016 |
25 |
5 |
p. 472-478 |
artikel |
11 |
Psychological distress in corticosteroid-naive patients with systemic lupus erythematosus: A prospective cross-sectional study
|
Nishimura, K |
|
2016 |
25 |
5 |
p. 463-471 |
artikel |
12 |
Successful treatment of severe refractory lupus hepatitis with mycophenolate mofetil
|
Tagawa, Y |
|
2016 |
25 |
5 |
p. 543-546 |
artikel |
13 |
The spectrum of nasal involvement in systemic lupus erythematosus and its association with the disease activity
|
Kusyairi, K A |
|
2016 |
25 |
5 |
p. 520-524 |
artikel |
14 |
Understanding remission in real-world lupus patients across five European countries
|
Schneider, M |
|
2016 |
25 |
5 |
p. 505-512 |
artikel |
15 |
Validation of the Japanese version of the Systemic Lupus Activity Questionnaire that includes physician-based assessments in a large observational cohort
|
Okamoto, Y |
|
2016 |
25 |
5 |
p. 486-495 |
artikel |